Invus

Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved.

They know that real transformation takes time and that it is never a straight line. They fully align their incentives with their partners and have the wherewithal and long-term commitment to see through any bumps along the way.

They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.

Invus, established in 1985 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity, Seed investments across Information Services, Software, Health Care, Medical, Financial Services, Venture Capital, Incubators, Enterprise Software, Automotive, Manufacturing. The organization boasts a portfolio of 229 investments, with an average round size of $103.2M and 70 successful exits. Their recent investments include PatientsLikeMe, CommerceNet, Omidyar Network, Zero Motorcycles, PrimeraDx (Primera Biosystems). The highest investment round they participated in was $2767.5B. Among their most notable exits are PatientsLikeMe and CommerceNet. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.